Because both ApoAII-2 and ApoCIII-0 were decreased in pancreatic cancer patients and the distribution was mutually independent (Fig. S6), simple summing of the two biomarkers improved the AUC value to 0.903. The gene discussed is APOA2; the disease is familial pancreatic carcinoma.